In the STEP 3 randomised trial, once weekly semaglutide 2.4 mg used in obese adults without diabetes was associated with 4.9% incidence of gallbladder related disorders (mainly cholelithiasis) compared with 1.5% in the placebo group (1)
It is a quinolinium salt substituted at position 5 with an amino group and at position 1 with a methyl group
Oral semaglutide may be the ideal choice for you if: You have a fear of needles: Trypanophobia (fear of needles) is a major barrier for many patients
In RCTs comparing GLP-1RA and placebo, insulin doses were reduced before GLP-1RA initiation to avoid hypoglycemia, and close monitoring and insulin adjustments were done periodically
Each review covers availability, stated purity, testing, and COA, product form, who can buy, and one caveat worth knowing